A phase I study of CST 101 in patients with advanced solid tumors not susceptible to immunotherapies.
Phase of Trial: Phase I
Latest Information Update: 17 Mar 2016
At a glance
- Drugs CST 101 (Primary)
- Indications Adrenal cancer; Colon cancer; Lung cancer; Lymphoma; Medulloblastoma; Neuroectodermal tumours; Sarcoma; Solid tumours
- Focus Adverse reactions
- 17 Mar 2016 New trial record